WORLD HEALTH ORGANIZATION
Clinical Trials
108
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (91 trials with phase data)β’ Click on a phase to view related trials
Impact of Alcohol Health Messages in a Real-world Online Retail Setting
- Conditions
- Behaviour ChangeKnowledgeRisk PerceptionEmotional ResponseMessage PerceptionIntentionsSales
- First Posted Date
- 2025-08-11
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 5173
- Registration Number
- NCT07116447
- Locations
- πΈπͺ
Systembolaget mobile app, Stockholm, Sweden
Impact of Alcohol Labels in a Real-World Setting
- Conditions
- KnowledgeBehaviour ChangeRisk PerceptionIntentionSupport for Alcohol PoliciesEmotional ResponseProduct Appeal
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 1410
- Registration Number
- NCT06915298
- Locations
- πͺπΈ
Sampled supermarkets in selected city neighbourhoods, Barcelona, Spain
An Adolescent Health and Wellbeing Check-up Programme in Three African Cities (Y-Check)
- Conditions
- Health Care Seeking BehaviorAdolescent BehaviorHealth-Related BehaviorAdolescent Development
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 6000
- Registration Number
- NCT06090006
- Locations
- π¬π
Schools and Community Centers, Cape Coast, Ghana
πΏπΌSchools and community centers, Chitungwiza, Zimbabwe
Strengthening Contraceptive Counseling Services: Research Protocol for a Multi-phase Complex Intervention in Pakistan and Nigeria
- Conditions
- EmpowermentContraceptionDecision Making
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 7920
- Registration Number
- NCT06081842
Empowering Adolescents to Lead Change Using Health Data
- Conditions
- Healthy
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- World Health Organization
- Target Recruit Count
- 12612
- Registration Number
- NCT04963426
- Locations
- π¨π
WHO, Geneva, Switzerland
- Prev
- 1
- 2
- 3
- Next
News
WHO Adds GLP-1 Diabetes Drugs to Essential Medicines List, Excludes Weight-Loss Indication
The World Health Organization has added GLP-1 medications including semaglutide and tirzepatide to its essential medicines list for treating type 2 diabetes with comorbidities.
Saudi-US Collaboration Develops Smart Multi-Compartment Capsule for Personalized Drug Delivery
A joint research team from King Abdulaziz City for Science and Technology and the University of California, San Diego, has developed a breakthrough smart multi-compartment capsule that delivers multiple medications throughout the day using programmed release mechanisms.
Mount Sinai Researchers Discover Potent Monoclonal Antibodies Against Mpox with Complete Protection in Animal Models
Researchers at Mount Sinai identified three powerful monoclonal antibodies targeting the A35 viral protein that completely prevented death and protected rodents from severe mpox disease in laboratory studies.
ImmunityBio Launches Phase 2 Trial of ANKTIVA for Long COVID Treatment
ImmunityBio has initiated a Phase 2 study evaluating ANKTIVA (nogapendekin alfa inbakicept-pmln) as a potential treatment for long COVID, marking the first clinical trial of an IL-15 agonist for this indication.
Gilead's HIV Prevention Drug Yeztugo Exceeds Launch Expectations, Projected to Reach $5 Billion by 2031
Gilead Sciences' HIV prevention drug Yeztugo is performing "well ahead of expectations" following its recent US and European launch, with unaided awareness reaching 72% compared to typical industry launch levels.
Ivermectin Mass Treatment Reduces Malaria Transmission by 26% in Landmark BOHEMIA Trial
The BOHEMIA trial, the largest study on ivermectin for malaria to date, demonstrated a 26% reduction in new malaria infections when administered alongside standard bed nets in Kenya.
Venus Remedies Receives WHO GDP Certification for Advanced Digital Logistics Operations
Venus Remedies secured WHO Good Distribution Practices certification for its Supply Chain Unit-II in Baddi, Himachal Pradesh, following a rigorous independent audit by SGS.
SandboxAQ and iOncologi Partner to Develop AI-Driven mRNA Vaccine for Glioblastoma
SandboxAQ and iOncologi announced a strategic collaboration to develop a novel high-fidelity mRNA vaccine for glioblastoma, the most aggressive malignant brain tumor in adults.
Β£17.9 Million Wellcome Grant Funds Major Initiative to Combat Deadly Fungal Infections
A collaborative team from University of Dundee, GSK, and University of Exeter has received Β£17.9 million from Wellcome to develop new antifungal treatments over five years.
WHO Includes ArkBio's Ziresovir in Pediatric RSV Drug Priority List, Marking First Chinese Anti-RSV Drug Recognition
The World Health Organization has included ziresovir (10mg) from Shanghai Ark Biopharmaceutical in its PADO-RSV priority list, making it the first and only RSV antiviral drug selected for the program.